BioMed Realty, a unit of Blackstone, is acquiring a sprawling life-sciences and office campus in Boulder, Colo.—the latest sign that the city at the base of the Rocky Mountains is emerging as a hub for the biotechnology and pharmaceutical industries.
BioMed Realty acquired Flatiron Park, a one-million-square-foot, 22-building life science and office campus that is currently 90% leased to a mix of industry-leading technology and life science firms.
The campus traded for $600 million, according to the Wall Street Journal, and BioMed Realty has plans to invest another $200 million to in part convert some of the offices to life science space.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
